Back to today’s briefing

Story perspectives

Cambridge Scientists Develop Hopeful Drug Combo for B-ALL

5/21/2025

39 4

Summary

Story summary

Cambridge scientists have made a groundbreaking advancement in the fight against B-cell acute lymphoblastic leukaemia (B-ALL) by creating a promising drug combination of venetoclax and inobrodib. Currently undergoing tests in mice, this innovative treatment aims to reduce harmful side effects compared to traditional chemotherapy, offering hope for safer options, especially for children affected by this aggressive cancer.

1 of 1

Story summary

Cambridge scientists have made a groundbreaking advancement in the fight against B-cell acute lymphoblastic leukaemia (B-ALL) by creating a promising drug combination of venetoclax and inobrodib. Currently undergoing tests in mice, this innovative treatment aims to reduce harmful side effects compared to traditional chemotherapy, offering hope for safer options, especially for children affected by this aggressive cancer.